By Professor Michael Leonard Friedlander

Journal articles

Evans VE; Vockler C; Friedlander ML; Walsh B; Willcox MD, 2001, 'Lacroglobin in Human Tears, a Potential Marker for Cancer', Clinical and Experimental Ophthalmology, pp. 161 - 163

Evans VE; Vockler C; Friedlander ML; Walsh B; Willcox MD, 2001, 'Lacryglobin in human tears, a potential marker for cancer', Clinical and Experimental Ophthalmology, pp. 161 - 163

Bahar A; Taylor P; Andrews L; Proos AL; Burnett L; Tucker K; Friedlander M; Buckley M, 2001, 'The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data', Cancer, 92, pp. 440 - 445

Yang JL; Friedlander ML, 2001, 'Therapeutic Benefit of Nifedipine in Metastatic Colon Cancer with DNA Mismatch Repair Gene Defect: Clinical Observation and Supportive Laboratory Evidence', Lancet, pp. 1767 - 1768

Vergote I; Rustin GJS; Eisenhauer EA; Kristensen GB; Pujade-Lauraine E; Parmar MKB; Friedlander M; Jakobsen A; Vermorken JB, 2000, 'Re: New guidelines to evaluate the response to treatment in solid tumors [ovarian cancer] [3]', Journal of the National Cancer Institute, 92, pp. 1534 - 1535

Meiser B; Butow P; Barratt A; Friedlander M; Kirk J; Gaff C; Haan E; Aittomäki K; Tucker K, 2000, 'Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer', Breast Cancer Research and Treatment, 59, pp. 101 - 111, http://dx.doi.org/10.1023/A:1006330631832

Rapley EA; Crockford GP; Teare D; Biggs P; Seal S; Barfoot R; Edwards S; Hamoudi R; Heimdal K; Fosså SD; Tucker K; Donald J; Collins F; Friedlander M; Hogg D; Goss P; Heidenreich A; Ormiston W; Daly PA; Forman D; Oliver RTD; Leahy M; Huddart R; Cooper CS; Bodmer JG; Easton DF; Stratton MR; Bishop DT, 2000, 'Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours', Nature Genetics, 24, pp. 197 - 200, http://dx.doi.org/10.1038/72877

Faulkner SW; Leigh DA; Oosterhuis JW; Roelofs H; Looijenga LHJ; Friedlander ML, 2000, 'Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: Evidence suggestive of the linear progression model', British Journal of Cancer, 83, pp. 729 - 736, http://dx.doi.org/10.1054/bjoc.2000.1334

Meiser B; Butow P; Friedlander M; Schnieden V; Gattas M; Kirk J; Suthers G; Haan E; Tucker K, 2000, 'Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer', Journal of Clinical Oncology, 18, pp. 2250 - 2257, http://dx.doi.org/10.1200/JCO.2000.18.11.2250

Faulkner SW; Friedlander ML, 2000, 'Microsatellite instability in germ cell tumors of the testis and ovary', Gynecologic Oncology, 79, pp. 38 - 43, http://dx.doi.org/10.1006/gyno.2000.5906

Faulkner SW; Friedlander ML, 2000, 'Molecular genetic analysis of malignant ovarian germ cell tumors', Gynecologic Oncology, 77, pp. 283 - 288, http://dx.doi.org/10.1006/gyno.2000.5762

Sanson-Fisher R; Girgis A; Boyes A; Bonevski B; Burton L; Cook P; Ackland S; Baker R; Berry M; Biggs J; Bishop J; Bokey L; Burnard A; Clingan P; Cregan P; Dunn S; Friedlander M; Goulston K; Hacker N; Kearsley J; Langlands A; Levi J; Moylan E; Stewart J; Tattersall M, 2000, 'The unmet supportive care needs of patients with cancer', Cancer, 88, pp. 225 - 236, http://dx.doi.org/10.1002/(sici)1097-0142(20000101)88:1<226::aid-cncr30>3.0.co;2-p

Marsden DE; Friedlander ML; Hacker NF, 2000, 'Current management of Epithelial Ovarian Carcinoma: A Review', Seminars in Surgical Oncology, 19, pp. 11 - 19

Bonevski B; Sanson-Fisher R; Girgis A; Burton L; Cook P; Boyes AW; Ackland S; Baker RW; Berry M; Biggs J, 2000, 'Evaluation of an instrument to assess the needs of patients with cancer', Cancer, 88, pp. 217 - 225

Friedlander ML, 1999, 'Multivariate prognostic models in ovarian cancer', CME Journal of Gynecologic Oncology, 4, pp. 256 - 258

Friedlander ML, 1999, 'Surgical stage, ascites, peritoneal cytology, tumour spillage, dense adherence', CME Journal of Gynecologic Oncology, 4, pp. 38 - 40

Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K, 1999, 'Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer', Gynecologic Oncology, 75, pp. 122 - 129, http://dx.doi.org/10.1006/gyno.1999.5544

Links MJ; Watson SR; Lethlean K; Aherne W; Kirsten F; Clarke SP; Law MG; Friedlander ML; Galettis P; Mckeage M, 1999, 'Vinblastine pharmacokinetics in patients with non-small cell lung cancer given cisplatin', Cancer Investigation, 17, pp. 479 - 485

Friedlander M, 1998, 'A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer', Annals of Oncology, 9, pp. 1343 - 1345, http://dx.doi.org/10.1023/A:1008469212268

Friedlander ML, 1998, 'Prognostic factors and tumour markers in ovarian teratomas', CME Journal of Gynecologic Oncology, 3, pp. 177 - 180

Friedlander ML, 1998, 'Prognostic factors in ovarian cancer', Seminars in Oncology, 25, pp. 305 - 314

Kefford R; Tucker K; Friedlander M; Kirk J, 1998, 'Cancer in the family. Part 2.', Australian family physician, 27, pp. 40 - 44

Zalcberg J; Millward M; Bishop J; McKeage M; Zimet A; Toner G; Friedlander M; Barter C; Rischin D; Loret C; James R; Bougan N; Berille J, 1998, 'Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer', Journal of Clinical Oncology, 16, pp. 1948 - 1953, http://dx.doi.org/10.1200/JCO.1998.16.5.1948

Hacker NF; Bancher-Todesca D; Williams KL; Neunteufel W; Friedlander ML, 1998, 'Influence of post operative treatment on survival in patients with uterine papillary serous carcinoma', Gynecologic Oncology, pp. 344 - 347

Links MJ; Ribeiro JC; Jackson P; Friedlander ML; Russell PJ, 1998, 'Regulation and deregulation of G2 checkpoint proteins with cisplatin', Anticancer Research, 18, pp. 4057 - 4066

Beller E; Tattersall M; Lumley T; Levi J; Dalley D; Olver I; Page J; Abdi E; Wynne C; Friedlander M; Boadle D; Wheeler H; Margrie S; Simes RJ, 1997, 'Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: A randomised placebo-controlled trial', Annals of Oncology, 8, pp. 277 - 283, http://dx.doi.org/10.1023/A:1008291825695

Friedlander M, 1997, 'A menopausal woman with a history of breast cancer: Should she receive HRT?', Modern Medicine of Australia, 40, pp. 164 - 165

Michael M; Bishop JF; Levi JA; Bell DR; Zalcberg JR; Friedlander ML; Olver LN; Smith JG; Toner GC, 1997, 'Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy', Medical Journal of Australia, 166, pp. 520 - 523, http://dx.doi.org/10.5694/j.1326-5377.1997.tb123243.x

Kefford R; Tucker K; Friedlander M; Kirk J, 1997, 'Cancer in the family. Guidelines for general practice.', Australian family physician, 26, pp. 545 - 549

Friedlander M; De Gramont A; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Rippche V; Kayitalire L, 1997, 'Activity of Gemcitablne in stage 3 or 4 ovarian cancer: Patients previously treated with cisplatin (CP)-containing regimens', European Journal of Cancer, 33, pp. S120 - S121, http://dx.doi.org/10.1016/s0959-8049(97)85054-x

Friedlander ML; Kerr JL; Hurst T; Shih A; Purdie DM; Bergman L; Chenevix-Trench G; Sanderson B; Zournazi A; Coombs T; Leary JA; Crawford E; Shelling AN; Cooke I; Ganesan TS; Searle J; Choi J; Barrett JW; Khoo SK; Ward B, 1997, 'Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations', Genes Chromosomes and Cancer, pp. 75 - 83

Friedlander ML; Tucker K, 1997, 'Hereditary ovarian cancer: genetic basic and management issues', Cancer Forum, 21, pp. 10 - 13

Kerr J; Leary JA; Hurst T; Shih YC; Antalis TM; Friedlander M; Crawford E; Khoo SK; Ward B; Chenevix-Trench G, 1996, 'Allelic loss on chromosome 7q in ovarian adenocarcinomas: Two critical regions and a rearrangement of the PLANH1 locus', Oncogene, 13, pp. 1815 - 1818

Zalcberg JR; Friedlander ML; Collopy BT; Barton M; Gray B, 1996, 'Treatment principles in advanced colorectal cancer (vol 66, pg 202, 1996)', AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 66, pp. 503 - 503, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996UX20100021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kavallaris M; Leary JA; Barrett JA; Friedlander ML, 1996, 'MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors', Cancer Letters, 102, pp. 7 - 16, http://dx.doi.org/10.1016/0304-3835(96)04143-2

Zalcberg JR; Friedlander ML; Collopy BT; Barton M; Gray B, 1996, 'Erratum: Treatment principles in advanced colorectal cancer (Australian and New Zealand Journal of Surgery (1996) 66 (202-205))', Australian and New Zealand Journal of Surgery, 66, pp. 503

Millward MJ; Bishop JF; Friedlander M; Levi JA; Goldstein D; Olver IN; Smith JG; Toner GC; Rischin D; Bell DR, 1996, 'Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer', Journal of Clinical Oncology, 14, pp. 142 - 148, http://dx.doi.org/10.1200/JCO.1996.14.1.142

Zalcberg JR; Friedlander ML; Collopy BT; Barton M; Gray B, 1996, 'Treatment principles in advanced colorectal cancer', Australian and New Zealand Journal of Surgery, 66, pp. 202 - 205, http://dx.doi.org/10.1111/j.1445-2197.1996.tb01164.x

Phillips KA; Fitzharris B; Friedlander M; McCrystal M; Olver I; Joughin J; Bishop J; Evans B; Smith J, 1995, 'Australasian multicentre phase II study of paclitaxel (Taxol) in relapsed ovarian cancer', Australian and New Zealand Journal of Medicine, 25, pp. 337 - 343, http://dx.doi.org/10.1111/j.1445-5994.1995.tb01899.x

Links M; Friedlander M, 1995, 'High-dose chemotherapy in gynaecological cancers: Does more mean better?', Current Opinion in Obstetrics and Gynecology, 7, pp. 49 - 52, http://dx.doi.org/10.1097/00001703-199507010-00010

De Souza PL; Friedlander ML, 1995, 'Humoral hypercalcemia associated with adenocarcinoma of the rectum: A case report and review of the literature', American Journal of Clinical Oncology: Cancer Clinical Trials, 18, pp. 126 - 129, http://dx.doi.org/10.1097/00000421-199504000-00006

Leary JA; Kerr J; Chenevix‐Trench G; Doris CP; Hurst T; Houghton CRS; Friedlanders ML, 1995, 'Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer', International Journal of Cancer, 64, pp. 189 - 195, http://dx.doi.org/10.1002/ijc.2910640308

Shannon JA; Donnellan MJ; Friedlander ML; Harnett PR, 1995, 'Persisting elevation of alphafetoprotein after chemotherapy for germ cell tumour-not always due to viable malignancy?', European Journal of Cancer, 31, pp. 1722, http://dx.doi.org/10.1016/0959-8049(95)00303-Z

Zalcberg JR; Bishop JF; Millward MJ; Zimet A; Laird J; Barter C; Seward D; McKeage MJ; Friedlander ML; Toner G; Berille J; Blanc C, 1995, '1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)', European Journal of Cancer, 31, pp. S226 - S226, http://dx.doi.org/10.1016/0959-8049(95)96330-g

Links M; Friedlander M, 1995, 'High-dose chemotherapy in gynaecological cancers', Current Opinion in Obstetrics and Gynecology, 7, pp. 49 - 52, http://dx.doi.org/10.1097/00001703-199502000-00010

Van Der Velden J; Gitch G; Wain GV; Friedlander ML; Hacker NF, 1995, 'Tamoxifen in patients with advanced epithelial ovarian cancer', International Journal of Gynecological Cancer, pp. 301 - 305

Gitch G; Friedlander ML; Wain GV; Hacker NF, 1995, 'Uterine papillary serous carcinaoma: a clinical study', Cancer, pp. 2239 - 2243

FRIEDLANDER M; LEWIS C; GOLDSTEIN D, 1994, 'UNTITLED', MEDICAL JOURNAL OF AUSTRALIA, 161, pp. 638 - 638, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PT68600027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

SEGELOV E; FRIEDLANDER M, 1994, 'PROGNOSTIC FACTORS FOR WOMEN WITH OVARIAN GERM-CELL TUMORS - REPLY', JOURNAL OF CLINICAL ONCOLOGY, 12, pp. 1738 - 1738, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PA25700031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chenevix-Trench G; Kerr J; Friedlander M; Hurst T; Sanderson B; Coglan M; Ward B; Leary J; Khoo SK, 1994, 'Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors', American Journal of Human Genetics, 55, pp. 143 - 149

Back to profile page